Tarsus Pharmaceuticals Cash Flow Statement 2019-2024 | TARS

Fifteen years of historical annual cash flow statements for Tarsus Pharmaceuticals (TARS).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-135.89$-62.09$-13.83$-26.81$-4.67
$-1.90$-0.68$0.61$0.25$0.07
$20.00$14.69$15.60$3.97$0.44
$18.09$14.01$16.20$4.22$0.51
$-16.62$0$0$0$0
$-3.11$0$0$0$0
$0$0$0$0$0
$6.79$-1.77$-2.51$-1.78$0.24
$0.31$-0.95$1.37$1.46$0.49
$-117.49$-49.03$3.75$-21.14$-3.67
$-1.50$-0.51$-0.59$-0.46$-0.18
$-4.00$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$146$-144.12$0$0$0
$146$-144.12$0$0$0
$0$0$0$0$0
$141$-144.63$-0.59$-0.46$-0.18
$10.00$20.00$0$0$0
$0$0$0$0$0
$10.00$20.00$0$0$0
$120$74.94$0.32$92.04$0
$120$74.94$0.32$132$0
$0$0$0$0$0
$0$-0.95$-0.30$0$59.45
$130$93.99$0.02$132$59.45
$153$-99.67$3.18$110$55.60
$19.83$13.46$8.46$0.84$0.02
$0$0$0$0$0